Skip to main content
Quest Diagnostics

Empowering Clinicians to Resolve VUS: Presenting VUS Clarification Outcomes

ACMG Annual Clinical Genetics meeting 2025

American College of Medical Genetics

Los Angeles, CA, Mar 18-21 , 2025

Poster presentation: Empowering Clinicians to Resolve VUS: Presenting VUS Clarification Outcomes

Authors: Fuqua L, Seppälä E, Toivonen M, Paczosa M, Ba S, Keller-Ramey J, Gall K, Partack E, Hathaway J, Sluyters A, Koskenvuo J

Specialty: Genetics

Disclaimer: One or more of the authors of this abstract were employed at the time by BluePrint Genetics, a subsidiary of Quest Diagnostics.

Related content

Publication
Distinct Rates of VUS Reclassification Are Observed When Subclassifying VUS by Evidence Level
Publication
The landscape of reported VUS in multi-gene panel and genomic testing: time for a change
Conference Presentation
Reclassifying Promising Variants of Uncertain Significance (VUSs) Using a Proactive VUS Clarification Service
Audio Podcast
Growing as a Laboratory Partner
On-Demand Webinar
How to Close Gaps in Care by Maximizing the Power of Laboratory Stewardship Solutions
Publication
Diagnostic Stewardship-Our Past, Our Current Status, and Future Promis

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2025 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.